Delivery Order SPE2DB20D1100-SPE2DB24FB3D2
Award Date 4/16/24
Potential Completion Date 4/17/24
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of 4,567,227,090 units of 4 mg Ondansetron HCL tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $2,294.40 firm-fixed-price delivery order contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 11, 2025, with a completion date of February 12, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
- This federal contract award is for the delivery of 4,566,165,480 units of ondansetron HCL 4 mg tablets to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $22,056.48, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 21, 2024, with a completion date of October 22, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of 4,560,801,374 units of Ondansetron HCL 4 mg tablets to the Defense Logistics Agency (DLA). The $9,146.70 firm-fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on May 2, 2023, with a completion date of May 3, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award is for the delivery of 4 mg Ondansetron HCL tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $11,812.99 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 16, 2023 and was not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award by the Defense Logistics Agency (DLA) is a Delivery Order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of 4 mg Ondansetron HCl tablets. The $9,937.88 Firm Fixed Price contract has a completion date of January 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ondansetron HCL 4 mg tablets. The $2,266.29 firm fixed-price contract has a completion date of May 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This federal contract award is for the provision of 4,564,949,977 units of 4 mg ondansetron orally disintegrating tablets to the Defense Logistics Agency (DLA). The $4,244.60 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, on June 19, 2024 with a completion date of June 20, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical as the...
- This federal contract award is for the delivery of 4,564,313,859 units of ondansetron ODT 4 mg tablets to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $3,795.23 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $1,940.22 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 6, 2025. The contract has a completion date of March 7, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is a delivery order valued at $1,187.71 for the supply of 30 units of the medication Ondansetron HCL 4 mg Tablets. The award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through...